Gates Foundation Gives Aids Scientists $287m
Three British scientists looking for an Aids vaccine will be among the collaborators receiving a massive $287m (£156m) funding injection from the Bill and Melinda Gates Foundation, it was announced last night.
Three British scientists looking for an Aids vaccine will be among the collaborators receiving a massive $287m (£156m) funding injection from the Bill and Melinda Gates Foundation, it was announced last night.
The grant is the biggest ever given by the Foundation to HIV/Aids research. It will be shared among 16 research projects in 19 countries.
All the scientists involved have signed an unprecedented collaboration agreement and will openly share their data and results in the hope of getting the most promising vaccine candidate quickly into clinical trials in humans.
The grant is the biggest ever given by the Foundation to HIV/Aids research. It will be shared among 16 research projects in 19 countries.
All the scientists involved have signed an unprecedented collaboration agreement and will openly share their data and results in the hope of getting the most promising vaccine candidate quickly into clinical trials in humans.
Use the feedback form below to submit your comments.
Use the form below to email this article to your friends.
- Gates Foundation Announces $500M Grant for AIDS Research and Care
- Bill and Melinda Gates Foundation Invests $21 Million in Chicago Schools
- Race is on to Save the First Aids Vaccine. But Does It Even Work?
- Discovery of Immune Group in Uganda Raises Aids Vaccine Hopes
- Aids vaccine 'may be ready within five years'
- Aids Vaccine Possible By 2012, Brown Tells Africa
- Aids Vaccine Fails Clinical Tests
- Uganda starts human trials of Aids vaccine
- Hope rises in Africa for Aids vaccine
- $25m Gates Gift to Gm Project Under Fire
- Gates and Buffett Plan Healthy Investment
- Gates Says Day of the Home-help Robot is Near
- Africa seeks funds for Aids research
- Bill Gates Biography
- Bill Gates – A story of Success
- Merck Halts HIV Vaccine Trial: Vaccine is "Ineffective"
- Microsoft Sees Growing Pains at 30